Document Detail

HLA alloimmunization in Egyptian aplastic anemia patients receiving exclusively leukoreduced blood components.
MedLine Citation:
PMID:  23084959     Owner:  NLM     Status:  Publisher    
BACKGROUND: The aim of the work was to detect the presence of anti-human leukocyte antigens (anti-HLAs) class I and II antibodies in sera of multitransfused aplastic anemia pediatric patients using two different techniques. The effect of the implemented transfusion practice on the frequency of these antibodies was studied as well as their effect on the patient's clinical condition. METHODS: Flowcytometry panel reactive antibodies (FlowPRAs) for HLA class I and II were determined and compared to the results obtained by Complement-dependent-cytotoxicity (CDC) assay. RESULTS: Over the past 3years, 20 aplastic anemia patients received leukoreduced blood components, 5/20 patients received leukoreduced products exclusively throughout their disease (group1), 15/20 patients had received non-leukoreduced components previously (group2). None of the patients in group1 was FlowPRA positive. Six patients from group2 (40%) were FlowPRA positive, only four out of these six patients showed positive CDC test. Positive and negative predictive values of CDC were 44.4 and 81.4% respectively, with 65% accuracy. Platelet refractoriness was encountered in 13/20 patients; only 3 out of these 13 patients (23%) were FlowPRA I positive (38±18%). One refractory patient died from intracranial hemorrhage. His FlowPRA I was 65.7% and CDC assay failed to detect it. CONCLUSION: Leukoreduction of blood components minimizes the incidence of HLA alloimmunization. Further investigations for other immune causes of platelet refractoriness are recommended. FCM is a simple and reliable technique for detection of anti-HLA antibodies, while CDC assay lacks sensitivity and specificity.
Azza Ahmed Aboul Enein; Nermeen Ahmed El Desoukey; Eiman Abdel Wahab Hussein; Mona Hamdi; Nada Adnan Jamjom
Related Documents :
6110669 - Multiple endocrine neoplasia with skeletal manifestations.
21817979 - How much free fluid can a pregnant patient have? assessment of pelvic free fluid in pre...
2429019 - Increased heterogeneity of serum thyroglobulin in thyroid cancer patients as determined...
8557859 - Alopecia areata in korea (1982-1994).
21700409 - Clinical usefulness of free-breathing navigator-triggered 3d mrcp in non-cooperative pa...
15657569 - The coming of age of radiation-induced hyperparathyroidism: evolving patterns of thyroi...
23057579 - The frequency of cerebral microbleeds increases with chads(2) scores in stroke patients...
3184289 - Gastrocystoplasty: an alternative solution to the problem of urological reconstruction ...
10764149 - Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elde...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-16
Journal Detail:
Title:  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis     Volume:  -     ISSN:  1473-0502     ISO Abbreviation:  Transfus. Apher. Sci.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101095653     Medline TA:  Transfus Apher Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Clinical Pathology, Faculty of Medicine, Cairo University, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Double Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Results In Successful Engraftme...
Next Document:  Costs of different follow-up strategies in early breast cancer: A review of the literature.